XML 46 R32.htm IDEA: XBRL DOCUMENT v3.25.0.1

Revenue (Tables)

12 Months Ended

Dec. 31, 2024

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregated Revenue

The following table presents our disaggregated revenue for the periods presented (in thousands):

		Year Ended December 31,
		2024				2023				2022
MRD revenue
Service revenue		$	133,029			$	102,739			$	81,144
Regulatory milestone revenue			12,500				—				6,000
Total MRD revenue			145,529				102,739				87,144
Immune Medicine revenue
Service revenue			19,976				24,959				31,777
Collaboration revenue			13,452				42,578				66,387
Total Immune Medicine revenue			33,428				67,537				98,164
Total revenue		$	178,957			$	170,276			$	185,308

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration